serena williams on glp-1 Reveals She Used Medication to Lose 31 Pounds Tennis legend Serena Williams has disclosed that she has been using a GLP-1 medication to support her recent weight loss journey Inside Serena Williams' partnership with

BPC-157 is administered as a subcutaneous injection (a shallow, small-needle injection into fatty tissue, similar to an insulin injection)

Regular bloodwork every three to six months helps monitor metabolic improvements and catch any unexpected changes early

Reapply every 23 hours when outdoors

Furthermore, a 5-year surveillance study of 1,954 patients with diabetes found that GI side-effects associated with acarbose were reported by only 3.9% of patients (Table 2)[18, 69]

Therefore, we think that declining of GLP-1 receptor expression in aorta in obese subjects may be involved in such high frequency of macrovascular complications